logo
How soup might soothe symptoms and support recovery from colds and flu

How soup might soothe symptoms and support recovery from colds and flu

Yahoo9 hours ago
For generations, chicken soup has been a go-to remedy for people feeling under the weather. It holds a cherished place in many cultures as a comforting treatment for colds and flu. But is there any real science behind the idea that soup can help us recover from respiratory infections?
Alongside colleagues, I conducted a systematic review to explore this question, which examined the scientific evidence on the role of soup in managing acute respiratory tract infections, such as the common cold, influenza and COVID-19.
Out of more than 10,000 records, we identified four high-quality studies involving 342 participants. These studies tested a variety of soups, including traditional chicken broth, barley soup and herbal vegetable blends. While still early-stage, the evidence was promising.
Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences.
One study found that people who ate soup recovered up to 2.5 days faster than those who didn't. Symptoms such as nasal congestion, sore throat and fatigue were milder. Some participants also showed reduced levels of inflammation-related markers: substances in the blood that rise when the immune system is fighting an infection.
Specifically, levels of IL-6 and TNF-α – two proteins that help trigger inflammation – were lower in those who consumed soup. This suggests that soup may help calm an overactive immune response, potentially making symptoms less severe and recovery more comfortable.
However, none of the studies examined how consuming soup influenced everyday outcomes of acute respiratory tract infections, such as whether people took fewer days off work or were less likely to end up in hospital. That's a major gap in the evidence, and one that future research needs to address.
There are several reasons soup may help. It's warm, hydrating and typically nutrient-rich. Ingredients like garlic, onion, ginger and leafy greens have anti-inflammatory, antimicrobial, and immune-supportive properties. The warmth can also help loosen mucus, soothe sore throats and promote overall comfort during illness.
There's also a strong cultural and behavioural aspect to food-based self-care: when people use food not just for nourishment, but as an intentional part of managing illness and promoting recovery.
In many households, food becomes medicine not only because of its ingredients, but because it symbolises care, routine and reassurance.
My previous research found that parents, in particular often turn to traditional remedies, like soup, as a first line of defence when illness strikes, often well before seeking professional medical advice.
This reflects a growing interest in home remedies and the importance of culturally familiar treatments: remedies that feel safe, trusted and emotionally resonant because they're part of a person's upbringing or community norms. These kinds of treatments can increase confidence and comfort when self-managing illness at home.
Food-based self-care may become increasingly important as pressure on healthcare systems continues to grow. With rising concerns about antimicrobial resistance, overstretched services, and lingering trauma from global pandemics, simple, evidence-informed home treatments can play a crucial role.
They help people manage mild illness, reduce unnecessary antibiotic use and avoid placing additional strain on GPs or emergency departments for minor ailments that can be safely treated at home. Even a simple phone message about the common cold – 'Most common colds get better in a few days and don't need treatment from your GP' – has been shown to reduce appointment demand by 21%, highlighting how low-cost, home-based care could ease pressure across the system.
The Local Government Association (LGA) reports that GPs handle approximately 57 million cases of minor conditions such as coughs and colds annually, costing the NHS over £2 billion a year. It argues that educating people about effective self-care could help save GPs an hour a day on average.
So chicken soup is easy to prepare, affordable, safe for most people and widely recognised as a comforting, familiar home remedy for minor illness.
Still, our review highlighted a clear need for more research. Future studies could examine standardised soup recipes and investigate whether particular combinations of nutrients or herbs work best: does chicken soup have the same effect as barley broth or vegetable potage? Is there a difference if it's homemade versus canned?
Just as importantly, future research needs to measure meaningful outcomes: how quickly people return to work or school, how well they sleep during illness, how they rate their comfort and energy levels, for example.
Soup isn't a replacement for medicine. But alongside rest, fluids and paracetamol, it might offer a simple way to ease symptoms and help people feel better.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Sandra Lucas does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

More than 14 million children worldwide have never received a single dose of any vaccine, new report warns
More than 14 million children worldwide have never received a single dose of any vaccine, new report warns

Yahoo

timean hour ago

  • Yahoo

More than 14 million children worldwide have never received a single dose of any vaccine, new report warns

An estimated 14.3 million children globally remain completely unvaccinated, according to a new report, and public health experts point to conflict zones as threatening childhood vaccination efforts worldwide. Each year, the World Health Organization and the United Nations Children's Fund publish a comprehensive report on estimates of national immunization coverage, based on data from 195 countries. This year's report, released Monday, says there have been some improvements in protecting children against certain diseases through routine vaccinations. Globally, 171,000 fewer children remained unvaccinated last year than in 2023, according to the report. But that still leaves more than 14 million children vulnerable to vaccine-preventable diseases and an additional 5.7 million with only partial protection because they may not have gotten all the recommended doses of certain vaccine series. 'The latest estimates highlight a really concerning trajectory,' Dr. Kate O'Brien, director of WHO's Department of Immunization, Vaccines and Biologicals, said in a news briefing. 'The global vision is for everyone everywhere to benefit from lifesaving vaccines,' she said. 'But we've hit this very stubborn glass ceiling, and breaking through that glass to protect more children against vaccine-preventable diseases is becoming more difficult.' Rising conflicts and war zones emerging around the world have eroded some of the progress in providing children with immunizations, she added, leading to many children remaining unvaccinated, especially in low- or middle-income countries. 'Children living in one of 26 countries affected by fragility, conflict or humanitarian emergencies are three times more likely to be unvaccinated compared to children who live in stable countries,' O'Brien said. 'In fact, half of all children unvaccinated in the world live in these fragile, vulnerable and conflict countries.' The new report says that last year, nine countries – Nigeria, India, Sudan, the Democratic Republic of Congo, Ethiopia, Indonesia, Yemen, Afghanistan and Angola – accounted for 52% of all children who have never received a dose of vaccine. Meanwhile, mostly in high-income countries, vaccine coverage has been affected by vaccine hesitancy and distrust in institutions, leading to a resurgence of vaccine-preventable diseases including measles and polio, said Dr. Ephrem Lemango, UNICEF's associate director for health and global chief of immunization. 'Based on all we know, over the past 50 years, over 150 million lives were saved through vaccination, and this has been able to protect children from any forms of vaccine-preventable diseases,' Lemango said at the briefing. 'But misinformation and any forms of vaccine hesitance is a reflection of a broader lack of trust or mistrust in the systems that deliver the vaccines, in the health workers that provide the vaccines and in the manufacturing facilities or the ecosystems that manufacture the vaccines,' he said. 'So it is important to see misinformation or lack of information as part of a broader ecosystem to be able to address.' Misinformation appears to be driving outbreaks of disease in pockets of countries that tend to have high vaccination rates, O'Brien said. 'There are communities sort of hidden under that national number that have very low vaccination coverage, and that's where outbreaks are happening, and those children are the ones who are suffering,' she said. In the United States, a measles outbreak that originated in a part of West Texas that has a low vaccination rate continues to spread, and there have been more measles cases reported in the US this year than any other since the disease was declared eliminated a quarter-century ago. But O'Brien added that while the effects of misinformation remain concerning, they are not the main reason millions of children remain unvaccinated globally. 'The main reason, when you look worldwide, why children aren't vaccinated is because of access to vaccines and access to vaccination services – and this is where it's particularly important,' O'Brien said. 'They're not being vaccinated because they don't have access,' she said. 'They're in dangerous settings, it's hard to gain access to them, and in some situations, the government does not have access to those environments.' The new report comes amid growing concern about funding for global vaccination efforts. The Trump administration has dismantled the US Agency for International Development, or USAID, which has partnered with organizations like Gavi, the Vaccine Alliance to provide vaccines. And the US has announced plans to reduce funding for the Global Fund to Fight AIDS, Tuberculosis and Malaria. 'We still have a lot of work to do,' WHO Director-General Dr. Tedros Adhanom Ghebreyesus said in a news release. 'Drastic cuts in aid, coupled with misinformation about the safety of vaccines, threaten to unwind decades of progress. WHO remains committed to working with our partners to support countries to develop local solutions and increase domestic investment to reach all children with the lifesaving power of vaccines.' The new report says that in 2024, protection against diphtheria, tetanus and pertussis remained constant, as an estimated 89% of infants globally received at least one dose of the DTP vaccine, the same share as in 2023 and 2022. Roughly 85% completed all three recommended doses of vaccine last year, compared to 84% in 2023 and 85% in 2022. The percentage of children receiving their first dose of measles vaccine remained relatively constant last year, at 84%, compared to 83% in 2023 and 2022. But that share is lower than in 2019, when coverage was 86%, according to the new report. Overall, the report says, 20.6 million children missed their routine first dose of measles vaccine last year. Meanwhile, the global percentage of children receiving their second dose of measles vaccine increased from 73% in 2022 and 74% in 2023 to 76% in 2024, according to the new report. In the United States, childhood vaccine coverage has been declining, and the vast majority of measles cases this year – more than 90% – have been in people who were unvaccinated or whose vaccination status was unknown, according to the US Centers for Disease Control and Prevention. 'The good news is that we have managed to reach more children with life-saving vaccines. But millions of children remain without protection against preventable diseases, and that should worry us all,' UNICEF Executive Director Catherine Russell said in the news release. 'We must act now with determination to overcome barriers like shrinking health budgets, fragile health systems along with misinformation and access constraints because of conflicts. No child should die from a disease we know how to prevent.' O'Brien said there has been 'incredible improvement' in global coverage of the HPV vaccine, which helps protect against the human papillomavirus, which can cause cervical cancer and other related diseases. The percentage of girls receiving a first dose increased to 31% in 2024, from 27% in 2023 and 20% in 2022. The percentage receiving all the doses of vaccine recommended in their country increased to 28% in 2024, from 21% in 2023 and 14% in 2022, according to the new report. HPV vaccine coverage was somewhat stable among boys, with 8% receiving a first dose in 2024 and 2023. 'This is a real bright spot in the data that, again, year on year now, we're seeing increases in HPV vaccine coverage,' O'Brien said, adding that recent increases are largely attributable to the introduction of the vaccine in Nigeria, Bangladesh and four other countries. Overall, the new report shows that although there hasn't been a significant retreat in childhood vaccine coverage globally, there hasn't been significant improvement either, said Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, who was not involved in the report. 'Fourteen million children who have received no vaccines is 14 million too many. Childhood vaccination is one of the most cost-effective medical interventions that's ever been developed,' Barouch said. 'I would hope that global health authorities prioritize childhood vaccination programs and that funding mechanisms are developed to ensure the continuation of these programs.'

Biggest human imaging study scans 100,000th person
Biggest human imaging study scans 100,000th person

Yahoo

timean hour ago

  • Yahoo

Biggest human imaging study scans 100,000th person

Scientists say they can study our bodies as we age in greater detail than ever before, thanks to more than a billion scans of UK volunteers. The world's biggest human imaging project says it has now hit its target of scanning the brains, hearts and other organs of 100,000 people - the culmination of an ambitious 11-year study. "Researchers are already starting to use the imaging data, along with other data we have, to identify disease early and then target treatment at an earlier stage," says Prof Naomi Allen, chief scientist at UK Biobank. The data is made available at low cost to teams around the world to find new ways of preventing common health conditions from heart disease to cancer. The 100,000th volunteer to be scanned was Steve, who recently retired from a job in sales and now helps out at a charity run by his daughter. The BBC watched as he entered a full-body MRI scanner in an industrial park outside Reading, and detailed images of brain cells, blood vessels, bones and joints appeared on the screens. "My mum was diagnosed with early-stage dementia a few years ago and has not been well," he says. "So with that in mind I want to give more back to research so the next generation can learn from people like me." The giant medical imaging project has been running for 13 hours a day, seven-days-a-week across four sites in England. Participants are given a five-hour appointment to be scanned using five different types of MRI, X-ray and ultrasound machines. The data gathered is anonymised and volunteers like Steve receive no individual feedback unless the radiographers happen to spot a potentially serious health problem. The project does not allow personal data, such as a volunteer's surname or the precise area where they live, to be published. Launched in 2003, UK Biobank is one of the largest collections of biological samples and health data in the world. In total, half a million people – all middle-aged volunteers – have been asked to complete physical tests, answer regular health and lifestyle questions, and provide DNA and other biological samples. Their blood, urine and saliva are frozen in liquid nitrogen and stored at temperatures of -80C (-112F) in huge refrigerators in Stockport, Greater Manchester. The imaging part of the project began in 2014, and involves taking detailed scans of 100,000 of those same participants. All of that group will be invited back to repeat the process every few years to see how their bodies and organs change as they grow older. By combining those scans with the other data collected by UK Biobank, scientists can test whether early changes to the make-up of the brain or body then lead to diseases or other health problems in later life. The whole UK Biobank project, which is non-profit making, was set up by the Medical Research Council and the Wellcome Trust charity, along with the Department of Health and the Scottish government. Two decades later it is now reaching maturity. Over 30 petabytes, or 30,000 terabytes, of anonymised health data is already available to researchers working for universities, charities, governments and the private sector. Scientists in the UK and the rest of the world can apply for access and most are charged between £3,000 and £9,000 to help cover running costs. DNA store has 'revolutionary' effect -scientists Genetics data release 'could lead to better treatment' UK biobank opens to researchers Louise Thomas, professor of metabolic imaging at the University of Westminster, says it is "completely transforming" how she and other researchers do their jobs. "We thought it was a crazy idea, there was absolutely no way anybody could scan this number of people," she says. "To analyse these images manually would have taken us thousands of years but now... we can extract all the information automatically, so we can measure everything in the body in a matter of minutes." Researchers are increasingly using artificial intelligence (AI) to process the huge amounts of data generated by the project. Almost 1,700 peer-reviewed papers have been written using all types of Biobank data since work started in 2003, with dozens more now published every week. The scans and images taken so far have already been used to show that: The early onset of 38 common diseases can be predicted by combining MRI scans with other health data and an artificial intelligence (AI) model Consumption of just small amounts of alcohol each day can be linked to an increased risk of memory loss and dementia A detailed MRI scan can replace surgery to diagnose and monitor a common form of liver disease Changes to the structure of the heart may lead to an increased risk of psychiatric disorders including depression UK Biobank is one of the 10 largest stores of personal health data in the world alongside similar initiatives in Germany, China and the United States, although those projects don't all make their data available to scientists globally in the same way. The imaging element of the project is also funded by a number of other organisations including the British Heart Foundation, Calico, a subsidiary of Alphabet which also owns Google, and the Chan Zuckerberg Initiative, established by Facebook founder Mark Zuckerberg and his wife Priscilla Chan.

UN says 14 million children did not receive a single vaccine in 2024
UN says 14 million children did not receive a single vaccine in 2024

Washington Post

time2 hours ago

  • Washington Post

UN says 14 million children did not receive a single vaccine in 2024

LONDON — More than 14 million children did not receive a single vaccine last year — about the same number as the year before — according to U.N. health officials. Nine countries accounted for more than half of those unprotected children. In their annual estimate of global vaccine coverage, released Tuesday, the World Health Organization and UNICEF said about 89% of children under one year old got a first dose of the diphtheria, tetanus and whooping cough vaccine in 2024, the same as in 2023. About 85% completed the three-dose series, up from 84% in 2023.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store